Chuck Ence

Chief Financial Officer, NewAge, Inc.

Companies

RELMADA THERAPEUTICS, INC.Chief operating officer Nov 6, 2025 to now¹
RELMADA THERAPEUTICS, INC.Chief Compliance Officer Jan 11, 2021 to now²
RELMADA THERAPEUTICS, INC.Chief financial officer Jul 30, 2019 to Dec 23, 2019³
NewAge, Inc.Chief financial officer Feb 14, 2017 to Feb 14, 2017⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

RELMADA THERAPEUTICS, INC. RLMD403,931 shares⁵$1.3M at $3.21Nov 5, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 5, 2025Bought 136,000 shares at $2.20 of RELMADA THERAPEUTICS, INC.⁵
May 16, 2025Bought 228,961 shares at $0.45 of RELMADA THERAPEUTICS, INC.⁶
Jan 31, 2024Bought 13,670 shares at $4.05 of RELMADA THERAPEUTICS, INC.⁷
Jan 30, 2024Bought 14,500 shares at $3.87 of RELMADA THERAPEUTICS, INC.⁷
Jan 29, 2024Bought 10,800 shares at $3.65 of RELMADA THERAPEUTICS, INC.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRELMADA THERAPEUTICS, INC., Chief operating officer
2
SEC EDGARRELMADA THERAPEUTICS, INC., Chief Compliance Officer
3
SEC EDGARRELMADA THERAPEUTICS, INC., Chief financial officer
4
SEC EDGARNewAge, Inc., Chief financial officer
5
SEC EDGARRELMADA THERAPEUTICS, INC. shares after the filing of Nov 5, 2025
6
SEC EDGARForm 4 filed May 20, 2025
7
SEC EDGARForm 4 filed Jan 31, 2024